Current Funded Project

​

The Meghan Rose Bradley Foundation currently supports research being pursued by Dr. Ulrike Gerdemann at Boston Children's Hospital. The objective of his work is to improve immunotherapy of brain cancer. Specifically, they will identify why certain brain cancers are able to avoid targeting by immunotherapies using killer T cells. This information will be used to modify existing immunotherapies using killer T cells to make them more effective. If successful, this research may greatly expand the utility and robustness of immunotherapy to treat a wide range of brain cancers.